Ligand Pharma's Partner Novan Submits NDA For Berdazimer Gel For Treatment Of Molluscum

Ligand Pharmaceuticals Inc. (LGND) Friday announced that its partner Novan, Inc. (NOVN) has submitted a New Drug Application FDA for berdazimer gel, 10.3% for the topical treatment of molluscum contagiosum.

Berdazimer gel, 10.3% could release nitric oxide and has anti-viral activity. It is poised to be a first-in-class topical treatment for molluscum, an infection caused by a poxvirus. The infection will result in a benign, mild skin disease characterized by lesions that may appear anywhere on the body.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Retailers Macy's, Inc. (M) and Dollar General Corp. (DG) reported on Thursday that net profits for the first quarter declined from last year, with Macy's topping estimates, while Dollar General missed it. Net sales at both retailers missed expectations. Both Macy's and Dollar General also slashed their guidance for the full-year 2023. The U.S. Food and Drug Administration has warned certain retailers against unauthorized sales of popular disposable e-cigarettes, mainly various types of Puff and Hyde brand e-cigarettes. Under the retailer inspection blitz, warning letters have been issued to 30 retailers, including one distributor, for illegally selling such products. All products cited in the warning letters are disposable Tillamook County Creamery Association is recalling a limited quantity of family-size 1.5qt cartons of Tillamook Waffle Cone Swirl ice cream due to undeclared wheat and soy, known allergens, the U.S. Food and Drug Administration said. The Tillamook Waffle Cone Swirl ice cream was mistakenly packaged in a Tillamook Chocolate Peanut Butter ice cream carton.
Follow RTT